LUCDOffering•prnewswire•
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
Sentiment:Neutral (45)
Summary
(NASDAQ:LUCD) NEW YORK, Sept. 11, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the closing of its previously announced underwritten...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 11, 2025 by prnewswire